Questions
Tournaments
Services
News
Questions
Tournaments
Questions
Questions
More
Log in
Sign Up
Log in
Sign Up
11
435
forecasters
9
11 comments
435 forecasters
ACX 2024 Prediction Contest
3 more...
Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?
Follow
share
embed
Resolved
No
Timeline
Histogram
1d
1w
2m
all
Comments (11)
Timeline
Key Factors (0)
Question Info
Similar Questions
No key factors yet
Add some that might influence this forecast.
5 comments
63 forecasters
Semaglutide Approval Withdrawal by 2027
0.5%
chance
1 comment
53 forecasters
Oral Semaglutide Approval by 2027
82%
chance
0 comments
29 forecasters
Semaglutide/Cagrilintide Approval by 2027
53%
chance
5 comments
49 forecasters
GLP-1-based drug approval by 2029
79.4%
chance
3 comments
15 forecasters
Date Weight Loss Drug >25% Body Weight
Current estimate
10 Jun 2028
15 comments
52 forecasters
American Obesity Percentage in 2032
Current estimate
39.4%
2 comments
8 forecasters
Will the FDA reclassify retatrutide as a biologic by 2029?
34.5%
chance
0 comments
21 forecasters
Percentage of US adults with Diabetes 2032
Current estimate
16.5%